Infertility
Conditions
Keywords
in vitro fertilization, assisted reproduction techniques, noninvasive imaging of embryos, time lapse imaging of embryos, traditional morphological grading of embryos, prediction of blastocyst formation, infertility, male factor female factor, embryo viability
Brief summary
The purpose of this study is to demonstrate that the Eeva™ System is compatible with the Eeva 12-well Dish.
Detailed description
This study is designed to demonstrate that the Eeva System Software successfully tracks the embryo images and identifies the timing of key developmental events using the Eeva 12-well Dish. This is a prospective, observational, blinded, single arm, nonrandomized, single center clinical study. Images of developing embryos and Eeva predictions will be blinded to embryologists and physicians
Interventions
Eeva will image embryos through cleavage stage (Day 3). Embryologists will use Eeva results along with traditional morphological grading to assist in selecting embryo(s) for transfer or freezing.
Sponsors
Progyny, Inc.
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Women undergoing fresh in vitro fertilization treatment using their own eggs or donor eggs. * Subject is at least 18 years of age. * Subject has basal antral follicle count (BAFC) ≥ 12 prior to stimulation cycle. * Subjects has basal FSH \< 11 IU * Fertilization using only ejaculated sperm (fresh or frozen) - no surgically removed sperm. * Subject has at least 8 normally fertilized eggs (2PN) * Willing to have all 2PN embryos monitored by Eeva * Willing to comply with study protocol and procedures and able to speak English. * Willing to provide written informed consent.
Exclusion criteria
* Reinseminated eggs. * History of cancer. * Gestational carriers. * Planned preimplantation genetic diagnosis or preimplantation genetic screening. * Previously enrolled in this study * Concurrent participation in another clinical study. * Any other reason the Investigator believes the subject should not participate in the clinical study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| To validate and develop the Eeva Software. | 3 months | The clinical image data (embryos images) will be used to develop the Eeva System Software. The Eeva software validation will consist in comparing the specificity of the Eeva System Software Blastocyst Prediction from the Eeva 12-well Dish to the specificity of the Eeva System Software from the Eeva 25-well Dish (the specificity of the Eeva System Software from the Eeva 25-well Dish was previously determined during the Eeva System Study TST-1788-r). |
Secondary
| Measure | Time frame |
|---|---|
| Specificity and sensitivity and 95% confidence intervals of the Eeva System Software and the Embryologist Panel (also referred to as Panel) measurements will be computed. | 3 months |
Other
| Measure | Time frame |
|---|---|
| The postive/negative (in-window/out-window) agreement of the Eeva Software and Panel measurements will be compared. | 3 months |
| The Mean Absolute Difference (MAD) will be calculated between each observer (Eeva Software, Panelist 1, Panelist 2, and Panelist 3) | 3 months |
| Bland Altman plots for the differences between each observer. | 3 months |
Countries
United States
Outcome results
None listed